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Extrapulmonary tuberculosis (EPTB) is defined as tuberculosis 
(TB) of organs other than the lungs and usually results from 
lympho-haematogenous dissemination of the organism. The term 
disseminated TB refers to TB that involves multiple body systems, 
including the lungs. Target areas are usually those with high 
vascularity and include the lymph nodes, meninges, spleen, kidneys, 
spine and growing ends of bones. Additional sites of involvement 
include the pleura, pericardium, peritoneum, liver, gastro-intestinal 
tract, genito-urinary tract and skin.1,2 
Co-infection with HIV has a significant impact on the TB 
pandemic. HIV-infected individuals more commonly present with 
EPTB, disseminated disease and smear-negative TB, and more readily 
suffer recurrence of TB after treatment. EPTB occurs in only 15.0% 
of non-HIV TB patients and in up to 70.0% of HIV-positive TB 
patients, with the risks of EPTB and mycobacteraemia increasing 
with advancing immunosuppression.1,3,4 TB may also accelerate the 
progression of HIV infection to AIDS.5
Despite therapeutic advances, TB remains a serious health burden 
causing 3 million deaths per year globally.6 The situation in South 
Africa is one of the worst; in 2004 the TB case fatality rate was 
79/100 000 population, a rate of over twice the global average of 32/ 
100 000.7,8 
The Western Cape province in South Africa has the highest 
national TB rate of 810/100 000 (2003), and the frequency is 
increasing further.9,10 Over the past 7 years the number of TB cases 
has increased by 66.0% in the Cape Town metropole. In 2005 there 
were 25 000 active TB cases in Cape Town, and two-thirds of these 
patients were co-infected with HIV.11 
The effective control of TB depends to a significant extent on 
prompt diagnosis and early initiation of appropriate therapy. The 
diagnostic gold standard is a positive culture of the bacterium, but it 
may take up to 8 weeks to obtain this. Smear microscopy can provide 
earlier confirmation by demonstrating acid-fast bacilli (AFB), but 
smear-negative cases remain problematic. In these patients treatment 
may be delayed while awaiting culture results, increasing the risk of 
disease progression, disease transmission, morbidity and mortality.12 
EPTB and disseminated TB are difficult to diagnose, and invasive 
procedures may be needed to acquire adequate specimens for 
testing.13 The diagnosis of active EPTB requires the presence of at 
least one culture-positive specimen from an extrapulmonary site, 
histological evidence of AFB, or strong clinical evidence.14  
We evaluated the role of pericardial and abdominal ultrasound in 
the diagnosis of EPTB or disseminated TB with the primary objective 
of prospectively determining any ultrasound findings that could be 
used to indicate the presence of active EPTB or disseminated TB.
Methods 
Study design and study participants
A prospective descriptive and analytic cross-sectional study design 
was used to determine the ultrasound findings of diagnostic value in 
patients with subsequently proven TB. It was conducted at G F Jooste 
Hospital, a 200-bed acute care hospital in Cape Town and serving 
approximately 1.3 million of the overall Cape Town metropole 
population of 3.4 million people. It serves Khayelitsha and Nyanga, 
the sub-districts with the highest rates of HIV- and TB-related 
deaths.15 
The study comprised 300 consecutive patients admitted to the 
medical wards at G F Jooste Hospital between August 2004 and 
October 2004 with a clinically suspected diagnosis of EPTB or 
disseminated TB, defined as TB in any two extrapulmonary sites such Corresponding author: M N Patel (mpfiles@iafrica.com)
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Objective. Tuberculosis (TB) in patients with or without advanced 
HIV infection may present as smear-negative, extrapulmonary 
and/or disseminated forms. We studied the role of pericardial 
and abdominal ultrasound examinations in the determination of 
extrapulmonary or disseminated TB.  
Methods. A prospective descriptive and analytic cross-sectional 
study design was used to determine the ultrasound findings of value 
in patients with subsequently proven TB. Ultrasound examinations 
were performed on 300 patients admitted to G F Jooste Hospital 
with suspected extrapulmonary or disseminated TB.
Outcome measures. The presence of hepatomegaly, splenomegaly, 
lymphadenopathy (location, size and appearance), ascites, pleural 
effusions, pericardial effusions and/or splenic micro-abscesses was 
noted. Clinical findings, microbiological and serological data were 
also recorded, correlated and analysed. 
Results. Complete data sets were available for 267 patients; 91.0% 
were HIV positive, and 70.0% had World Health Organization 
clinical stage 4 disease. Active TB (determined by smear or culture) 
was present in 170 cases (63.7%). Ultrasonically visible abdominal 
lymphadenopathy over 1 cm in minimum diameter correlated with 
active TB in 55.3% of cases (odds ratio (OR) 2.6, 95% confidence 
interval (CI) 1.5 - 4.6, p=0.0002). Ultrasonographically detected 
pericardial effusions (OR 2.8, 95% CI 1.6 - 5.0, p<0.0001), ascites 
(OR 2.2, 95% CI 1.2 - 4.2, p=0.005) and splenic lesions (OR 1.9, 95% 
CI 1.0 - 3.5, p=0.024) also predicted active TB. 
Conclusion. Pericardial and abdominal ultrasound examinations 
are valuable supplementary investigations in the diagnosis of 
suspected extrapulmonary or disseminated TB.
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as lymph nodes, pericardium, peritoneum, nervous system, skeletal 
system, etc.  
Investigations and outcome measures
Ultrasound scans were performed with a Toshiba Eccocee machine, 
using a 3.5 - 5.0 MHz convex probe, as well as a 7.5 MHz linear probe 
where indicated. Nodes were actively sought in the para-aortic, peri-
pancreatic, peri-portal, splenic hilar, mesenteric and inguinal regions. 
Nodes larger than 10 mm were considered significant and their 
location was documented, in addition to their appearances and the 
minimum and maximum nodal dimensions, measured in the short 
axis diameter. The liver and spleen were examined for size and any 
focal lesions or abscesses. The presence of ascites, pleural effusions 
and pericardial effusions was noted.   
Microbiological samples, including sputum, urine, serous fluid, 
cerebrospinal fluid (CSF) and lymph node fine-needle aspirates, were 
sent for TB microscopy and culture, and radiography was performed at 
the discretion of the supervising clinician(s). The study protocol did not 
include routine HIV testing, but this was requested if clinically warranted. 
Ethics approval was obtained from the University of Cape Town’s 
Health Sciences Research Ethics Committee (rec ref 279/2004) and 
the Clinical Executive of G F Jooste Hospital.
Data analysis
The ultrasound findings, clinical records, radiographic findings and 
laboratory investigations were collected and entered into an Access 
(Microsoft, Redmond, WA, USA) database. The primary cohort 
was stratified according to the outcome measures. The data were 
extracted from the database onto an Excel (Microsoft) spreadsheet 
and analysed using STATA (Stata Statistical Software, release 7.0; 
StataCorp, 2001, College Station, TX, USA). Frequency and two-by-
two tables were generated. Odds ratios (ORs) and 95% confidence 
intervals (CIs) were calculated, and chi-square and Fisher’s exact 
tests were used for comparing proportions. A probability value (p) of 
≤0.05 was considered significant. Logistic regression analysis, using a 
model building technique, was performed to determine which of the 
ultrasound variables predicted TB infection. 
Results
Of the patients 267 (89.0%) had adequate laboratory specimens 
to confirm the presence or absence of active TB; 33 patients with 
inadequate samples were excluded. Patient ages ranged from 15 to 
86 years (mean 36.4 years, standard deviation (SD) 10.8 years); 174 
patients (65.2%) were female. 
HIV status was known in 221 patients (82.7%), of whom 201 
(91.0%) were HIV positive. Of the HIV-positive patients, 30.0% were 
in World Health Organization (WHO) clinical stage 3 and 70.0% in 
WHO clinical stage 4. Active TB (diagnosed by smear or culture) was 
present in 135 HIV-positive patients and 10 HIV-negative patients; 
the difference was not statistically significant (OR 1.9, 95% CI 
0. 7 - 5.2, p=0.18). 
In total, 170 of 267 patients (63.7%) were diagnosed with active 
TB by positive smear or culture. Culture-positive Mycobacterium 
tuberculosis was present in 134 patients (Table I).
Table II displays the salient ultrasound findings. Deep abdominal 
lymphadenopathy correlated significantly with active TB as diagnosed 
by smear or culture (OR 2.6, 95% CI 1.5 - 4.6, p=0.0002). In total, 
55.3% of the patients with active TB (diagnosed as above) had 
abdominal lymphadenopathy on ultrasound. The splenic hilar, 
para-aortic, peri-portal and peri-pancreatic nodal locations all 
corresponded significantly with active TB (95% CI 1.1 - 5.8, p=0.0002 - 
0.021). In 23 of 125 patients (18.4%) ultrasound examination detected 
abdominal lymphadenopathy, but TB could not be confirmed in 
these cases. 
Table II. Abdominal ultrasound findings
Active TB by smear or culture
Ultrasound findings OR 95% CI p-value Frequency
Lymphadenopathy 2.63 1.51 - 4.60 0.0002 55.3% (94/170)
Hepatomegaly 0.63 0.34 - 1.19 0.128 18.8% (32/170)
Splenomegaly 1.65 0.66 - 4.24 0.242 12.9% (22/170)
Splenic lesions 1.89 1.04 - 3.46 0.024 37.1% (63/170)
Ascites 2.24 1.22 - 4.15 0.005 38.2% (65/170)
Pericardial effusion 2.83 1.62 - 4.96 0.00008 55.9% (95/170)
Splenic lesions + 
lymphadenopathy
2.02 1.07 - 3.82 0.019 32.9% (56/170)
Splenic lesions + ascites 2.43 0.96 - 6.41 0.041 15.9% (27/170)
Splenic lesions + 
lymphadenopathy + ascites
2.86 1.07 – 8.07 0.02 15.9% (27/170)
Table I.  Frequency of laboratory specimen findings
Smear positive Culture positive
Sample (N) N % N %
Sputum (191) 72 37.7 120 62.8
CSF (18) 0   3 16.7
Urine (104) 6 5.8 24 23.1
Fine-needle aspiration 
(60)
30 50.0 8 13.3
Gastric washings (5) 1 20.0 1 20.0
Peritoneal fluid (9) 0 5 55.6
Pleural fluid (51) 3 5.9 30 58.8
Pericardial fluid (2) 0 2 100.0
Bone marrow (5) 4 80.0 1 20.0
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The presence of an ultrasonically detectable pericardial effusion 
also correlated significantly with active TB (diagnosed by smear or 
culture) (OR 2.8, 95% CI 1.6 -5.0, p<0.0001). 
Hepatomegaly and splenomegaly were present in 18.8% and 
12.9% of patients, respectively, but no significant correlation was 
evident when comparing liver and splenic size with TB. However, 
the correlation between the presence of splenic lesions and active 
TB (diagnosed by smear or culture) was significant (OR 1.9, 95% CI 
1.0 - 3.5, p=0.024). 
Ascites was present in 65 cases (38.2%) and correlated significantly 
with active TB (diagnosed by smear or culture) (OR 2.2, 95% CI 1.2 - 
4.2, p=0.005). 
The combinations of abnormal ultrasound findings that correlated 
significantly with active TB (diagnosed by smear or culture) are 
set out in Table II. Logistic regression analysis determined (with 
a decreased deviance of 30.1 and significance at the 5% level of 
p=0.0000) that abdominal lymphadenopathy, ascites and pericardial 
effusion were the ultrasound variables with the best predictive value 
for active TB (diagnosed by smear or culture). The model showed 
that the presence of abdominal nodes was associated with a 2.6 times 
increased risk of active TB, ascites with a 2.2 times increased risk, and 
pericardial effusion with a 2.8 times increased risk. In combination, 
the presence of lymphadenopathy, ascites and splenic lesions was 
associated with a 2.9-fold increased risk of active TB.  
Discussion
This study evaluating the role of abdominal and pericardial ultrasound 
in diagnosing patients with suspected EPTB or disseminated TB in 
267 patients is the largest conducted in South Africa to date. A study 
published in 2002 suggested that abdominal ultrasound might be 
an appropriate method to diagnose TB in the setting of repeatedly 
negative sputum smears, but made no mention of their study sample 
size.16 Reviewing a total of 35 ultrasound scans in patients with HIV 
and abdominal pain, Hudson and Wood found that a final diagnosis 
of TB was made in 12 cases and concluded that the role of ultrasound 
in the diagnosis of TB was limited.17 Others have also concentrated 
on HIV and TB, but none have investigated the role of ultrasound 
examination in the diagnosis of smear-negative TB.12,18-20 
We document a final sample of 170 patients (63.7% with suspected 
TB) subsequently diagnosed with active TB on the basis of smear 
or culture. The presence of intra-abdominal lymphadenopathy >10 
mm in diameter, splenic microabscesses and ascites, alone or in 
combination, was associated with a 3-fold increased risk of active 
TB. Although abdominal lymphadenopathy is a well-described 
manifestation of TB, the importance of this ultrasound finding 
in patients with proven TB in our study highlights the value of 
abdominal ultrasound examination in the investigation of patients 
with suspected disseminated or EPTB. In the appropriate clinical 
context, abdominal lymphadenopathy, particularly associated with 
splenic lesions and/or ascites found at ultrasound examination, could 
be used as a surrogate marker of TB while awaiting specimen culture 
results. 
Ultrasound is a cheap, non-invasive radiological modality.  Although 
operator interpretation is subjective and experience necessarily 
develops with time, the technique of scanning is readily taught, 
especially in the abdomen, and ultrasound scanning can therefore 
be widely practised. It could be especially useful in centres where the 
burden of TB is high, particularly in disseminated, smear-negative 
TB in HIV-positive patients. The appropriate use of ultrasound 
can potentially avert unnecessary delays in initiating treatment and 
decrease the diagnostic cost by avoiding invasive tests and tertiary 
referral. Since the majority of patients in our local setting are seen 
at the primary health care level, local access to ultrasound imaging 
modalities is important.  
Approximately 18.0% of patients (23 of 125) had abdominal 
lymphadenopathy that could not be confirmed to be of tuberculous 
origin. In these patients TB remained a probable diagnosis, but 
other diagnoses should be considered in such circumstances, e.g. 
systemic candidiasis, mycobacteria other than TB, Kaposi’s sarcoma, 
disseminated cryptococcosis or lymphoma. Direct sampling of these 
nodes was not undertaken in this study.  
The presence of ultrasonically detectable pericardial fluid was 
associated with a 2.8 times increased risk of TB and should be routinely 
sought when performing abdominal ultrasound examination on 
patients with suspected EPTB or disseminated TB. A local study on 
patients with pericardial effusions of 10 mm or more in size found 
that tuberculous pericarditis was present in 53%, 100% had an 
enlarged cardiothoracic ratio, and 45.5% were HIV positive.21 
Hepatomegaly and splenomegaly were not consistent findings in 
patients with active EPTB, in contrast to other studies.22-24 However, 
the presence of splenic micro-abscesses correlated significantly 
with active TB (OR 1.9, 95% CI 1.0 - 3.5, p=0.024). This finding 
emphasises the need for use of high-frequency ultrasound probes for 
early diagnosis, since the presence of splenic micro-abscesses in TB is 
known to be associated with increased mortality.13,25 
Ascites is a common finding in abdominal TB, and smear or 
culture tests on ascitic fluid are useful.24,26 Our study found ascites 
in 38.2% of cases and was associated with a 2-fold increased risk of 
active TB. Generally smears are positive in less than 5% of cases.1
Conclusion
Ultrasound examination of the abdomen and pericardial space may 
facilitate an early clinical diagnosis of TB in smear-negative HIV-
positive patients while awaiting bacteriological evidence of active 
TB. HIV and TB present the most serious challenges to public health 
across the world and need to be addressed urgently. By improving 
the index of suspicion of active TB, ultrasound examination may 
prevent unnecessary delays in initiation of therapy, limit disease 
transmission, curb the development of multidrug-resistant TB and 
reduce morbidity and mortality, particularly in smear-negative 
patients with EPTB or disseminated TB. 
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Palliative care improves care for people throughout the course of 
progressive incurable illness. There has been a worldwide effort to 
increase and improve palliative care education. The World Health 
Organization (WHO) challenged training institutions to ensure 
that palliative care was compulsory and given high recognition.1 
Education programmes in training institutions have found palliative 
care programming to be patchy or non-existent in developed2-6 and 
developing nations.7,8 As palliative care is in its infancy in South Africa, 
medical schools are only beginning to teach it now at undergraduate 
level, and do not offer postgraduate palliative care programmes.
In response to this lack of educational offerings, UCT began 
a postgraduate distance palliative care education programme for 
doctors in 2000. The programme, designed to be completed in 
2 - 3 years, offers a diploma and a master’s of philosophy degree. 
Assignments are e-mailed to students and, in their first 2 years, 
students also attend a 3-day face-to-face instruction workshop. 
Master’s students complete a research study.9
Programme planners and conveners believe that the programme 
has enhanced graduates’ abilities to attend to palliative and end-of-
life care issues. However, a formal evaluation was needed to assess 
its effect on the health care practices of course participants and the 
wider community. In the context of a larger descriptive study, we Corresponding author: C Ens (carla.ens@gmail.com)
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Aim. We aimed to assess the postgraduate palliative care distance 
education programme of the University of Cape Town (UCT) in 
terms of its perceived ability to influence palliative care delivery.
Methods. A mixed-methods approach, consisting of two surveys 
using open-ended and multiple-choice options, was conducted from 
January to December 2007 at the UCT School of Public Health and 
Family Medicine. All students registered in the programme from 
2000 - 2007 were invited to participate; 83 (66.4% of all eligible 
participants) completed the general survey, and 41 (65.7%) of the 
programme’s graduates completed the graduate survey. The survey 
scores and open-ended data were triangulated to evaluate UCT’s 
palliative care postgraduate programme.
Results. General survey scores of graduates were significantly 
higher in 5 of the 6 categories in comparison with current 
students. The graduate survey indicated that curriculum and 
teaching strengths were in communication and dealing with 
challenging encounters. Graduates also stressed the need to develop 
a curriculum that incorporated a practical component.
Conclusions. In addition to current postgraduate training, 
palliative care education in South Africa should be extended 
to undergraduate medical students, as the benefits of UCT’s 
programme were limited to a small cohort of practitioners.
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